BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 179 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,567,776 | +18.9% | 927,652 | +18.2% | 0.01% | +14.3% |
| Q2 2023 | $5,525,056 | +9.6% | 784,809 | +29.8% | 0.01% | +16.7% |
| Q1 2023 | $5,040,787 | -42.8% | 604,411 | -21.2% | 0.01% | -50.0% |
| Q4 2022 | $8,805,331 | +11.3% | 767,015 | +22.1% | 0.01% | +9.1% |
| Q3 2022 | $7,913,153 | +31.4% | 628,028 | +10.3% | 0.01% | -26.7% |
| Q2 2022 | $6,023,000 | +402.8% | 569,149 | +672.6% | 0.02% | +650.0% |
| Q1 2022 | $1,198,000 | +21.4% | 73,666 | +3.3% | 0.00% | 0.0% |
| Q4 2021 | $987,000 | -0.8% | 71,302 | +3.0% | 0.00% | 0.0% |
| Q3 2021 | $995,000 | -10.9% | 69,218 | -2.1% | 0.00% | 0.0% |
| Q2 2021 | $1,117,000 | +41.6% | 70,669 | -9.0% | 0.00% | 0.0% |
| Q1 2021 | $789,000 | +38.2% | 77,630 | +1.3% | 0.00% | +100.0% |
| Q4 2020 | $571,000 | +182.7% | 76,661 | +30.4% | 0.00% | – |
| Q3 2020 | $202,000 | -19.8% | 58,775 | +11.0% | 0.00% | -100.0% |
| Q2 2020 | $252,000 | +61.5% | 52,955 | -32.1% | 0.00% | – |
| Q1 2020 | $156,000 | -37.3% | 78,010 | +8.0% | 0.00% | -100.0% |
| Q4 2019 | $249,000 | +90.1% | 72,238 | +58.4% | 0.00% | – |
| Q3 2019 | $131,000 | -24.3% | 45,599 | 0.0% | 0.00% | – |
| Q2 2019 | $173,000 | -53.4% | 45,599 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $371,000 | +0.8% | 45,599 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $368,000 | +14.3% | 45,599 | +8.2% | 0.00% | 0.0% |
| Q3 2018 | $322,000 | +33.1% | 42,157 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $242,000 | +20.4% | 42,157 | 0.0% | 0.00% | – |
| Q1 2018 | $201,000 | -2.9% | 42,157 | 0.0% | 0.00% | – |
| Q4 2017 | $207,000 | +3.0% | 42,157 | +10.1% | 0.00% | – |
| Q3 2017 | $201,000 | -5.6% | 38,275 | 0.0% | 0.00% | – |
| Q2 2017 | $213,000 | -25.8% | 38,275 | +12.1% | 0.00% | -100.0% |
| Q1 2017 | $287,000 | +32.9% | 34,148 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $216,000 | +43.0% | 34,148 | 0.0% | 0.00% | – |
| Q3 2016 | $151,000 | +55.7% | 34,148 | 0.0% | 0.00% | – |
| Q2 2016 | $97,000 | 0.0% | 34,148 | 0.0% | 0.00% | – |
| Q1 2016 | $97,000 | -72.4% | 34,148 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $352,000 | -9.5% | 34,148 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $389,000 | -35.2% | 34,148 | -15.0% | 0.00% | 0.0% |
| Q2 2015 | $600,000 | +65.3% | 40,197 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $363,000 | -25.8% | 40,197 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $489,000 | +24.4% | 40,197 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $393,000 | -23.4% | 40,197 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $513,000 | – | 40,197 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
| Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
| DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
| Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
| Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
| Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
| KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
| Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |